Miriam B Vos1. 1. aEmory University bChildren's Healthcare of Atlanta, Atlanta, Georgia, USA.
Abstract
PURPOSE OF REVIEW: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and it has overlapping pathogenesis with diabetes and cardiovascular disease. Reviewed here are recent advances in understanding the contribution of diet and selected nutrients to NAFLD. RECENT FINDINGS: To understand the effect of diet, the microbiome must be considered because it is the interface of diet and the liver. Early studies suggest that the characteristic of the microbiota is altered in NAFLD. Fructose is a lipogenic carbohydrate that contributes to insulin resistance, hypertriglyceridemia and appears to be associated with the severity of NAFLD. Fructose absorption and malabsorption may alter the microbiota and could be mediating effects on the liver. Lipids also have potent microbiome interactions and could contribute to the benefit of diets emphasizing lipid changes. Several new studies demonstrate that the Mediterranean diet and 'lifestyle change' are effective in modestly improving NAFLD. A new study of 'lifestyle' in children showed simultaneous improvement in cardiovascular disease risk measurements and hepatic steatosis. SUMMARY: Current data supports limiting sugar in the diet and 'lifestyle change' as a first-line treatment for NAFLD; however, the benefits from these appear to be modest. The effects of diet on the liver are mediated through the microbiome and expansion of research in this area is needed.
PURPOSE OF REVIEW: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and it has overlapping pathogenesis with diabetes and cardiovascular disease. Reviewed here are recent advances in understanding the contribution of diet and selected nutrients to NAFLD. RECENT FINDINGS: To understand the effect of diet, the microbiome must be considered because it is the interface of diet and the liver. Early studies suggest that the characteristic of the microbiota is altered in NAFLD. Fructose is a lipogenic carbohydrate that contributes to insulin resistance, hypertriglyceridemia and appears to be associated with the severity of NAFLD. Fructose absorption and malabsorption may alter the microbiota and could be mediating effects on the liver. Lipids also have potent microbiome interactions and could contribute to the benefit of diets emphasizing lipid changes. Several new studies demonstrate that the Mediterranean diet and 'lifestyle change' are effective in modestly improving NAFLD. A new study of 'lifestyle' in children showed simultaneous improvement in cardiovascular disease risk measurements and hepatic steatosis. SUMMARY: Current data supports limiting sugar in the diet and 'lifestyle change' as a first-line treatment for NAFLD; however, the benefits from these appear to be modest. The effects of diet on the liver are mediated through the microbiome and expansion of research in this area is needed.
Authors: Sabine Wagnerberger; Astrid Spruss; Giridhar Kanuri; Carolin Stahl; Markus Schröder; Walter Vetter; Stephan C Bischoff; Ina Bergheim Journal: J Nutr Biochem Date: 2012-06-27 Impact factor: 6.048
Authors: Ran Jin; Ngoc-Anh Le; Shuling Liu; Monica Farkas Epperson; Thomas R Ziegler; Jean A Welsh; Dean P Jones; Craig J McClain; Miriam B Vos Journal: J Clin Endocrinol Metab Date: 2012-04-27 Impact factor: 5.958
Authors: Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco Journal: Hepatology Date: 2009-06 Impact factor: 17.425
Authors: Ryan W Walker; Kim-Anne Lê; Jaime Davis; Tanya L Alderete; Rebecca Cherry; Sylvie Lebel; Michael I Goran Journal: J Am Coll Nutr Date: 2012-10 Impact factor: 3.169
Authors: Miguel A Lanaspa; Takuji Ishimoto; Nanxing Li; Christina Cicerchi; David J Orlicky; Philip Ruzycki; Philip Ruzicky; Christopher Rivard; Shinichiro Inaba; Carlos A Roncal-Jimenez; Elise S Bales; Christine P Diggle; Aruna Asipu; J Mark Petrash; Tomoki Kosugi; Shoichi Maruyama; Laura G Sanchez-Lozada; James L McManaman; David T Bonthron; Yuri Y Sautin; Richard J Johnson Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: Richard D Johnston; Mary C Stephenson; Hannah Crossland; Sally M Cordon; Elisa Palcidi; Eleanor F Cox; Moira A Taylor; Guruprasad P Aithal; Ian A Macdonald Journal: Gastroenterology Date: 2013-07-19 Impact factor: 22.682
Authors: Ran Jin; Sophia Banton; ViLinh T Tran; Juna V Konomi; Shuzhao Li; Dean P Jones; Miriam B Vos Journal: J Pediatr Date: 2016-02-05 Impact factor: 4.406
Authors: Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg Journal: ILAR J Date: 2017-12-01
Authors: Jennifer E Lambert; Jill A Parnell; Bertus Eksteen; Maitreyi Raman; Marc R Bomhof; Kevin P Rioux; Karen L Madsen; Raylene A Reimer Journal: BMC Gastroenterol Date: 2015-12-03 Impact factor: 3.067